Jefferies upgrades Inovio stock rating on FDA review progress — See source for full details.
$INO
Price history, market instrument context, member research, and related headlines in one place.
INO key statistics
NasdaqCMUSD
52-week range
$0.5620%$2.72
Latest session $0.9583–$1.02Inovio Pharmaceuticals, Inc. (INO) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $0.986, down $0.01 (1.22%) from the previous close of $0.9982. It has traded between $0.9583 and $1.02 in the latest session. Over the past year it has ranged from $0.56 to $2.72, leaving it in the lower quarter of its 52-week range (20%). Reported volume for the session was 3M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Inovio targets Oct. 30, 2026 PDUFA as it extends cash runway into late Q1 2027 — See source for full details.
Inovio Pharmaceuticals GAAP EPS of -$0.07 beats by $0.15 — See source for full details.
Form 424B5 Inovio Pharmaceuticals Inc For: 30 July — See source for full details.
Inovio slumps 22% on pricing $20M stock offering — See source for full details.
Inovio prices $20 million public offering of stock and warrants — See source for full details.
Loading $INO research…